Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Gain valuable insights from women's financial planning case studies. Learn from real-life experiences to enhance your financial strategy.
22,562 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
As AI data centers surge, the race for reliable, green energy accelerates. This analysis explains how Oklo could beco...
Guardian (GRDN) is shaping up as a data-driven growth story in 2026. This deep dive breaks down the Q1 2026 earnings ...
Midday action hinges on Alphabet's report and the AI spend cycle. Learn what moves markets, how hyperscalers shape ri...
The CDC has expanded its Ebola response after the WHO declared an international public health emergency, deploying mo...
Kenya's High Court halted a U.S. plan to establish a quarantine facility for Americans exposed to Ebola, delaying a $...
In June 2026, one stock shines as a truly rated pick. This article explains why it earns the title and how everyday i...
An insider sold 50,000 shares of Hinge Health, prompting questions about the stock’s outlook. This guide breaks down ...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A new federal lawsuit alleges that U.S. immigration agencies shared confidential information about Iranian asylum see...
As regulators eye crypto privacy tools, the DOJ's push for an October retrial in the Tornado Cash case tests how far ...
A prominent quadruple amputee cornhole champion has been charged with murder following a fatal confrontation in Maryl...